We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use tewv.nhs.uk, remember your settings and improve our services.
We also use cookies set by other sites to help us deliver content from their services.
This document is the guidance for prescribing guanfacine indicated for the treatment of ADHD in children and adolescents aged 6-17 years old.
Follow us on social media for all the latest news and announcements
